Randomized Controlled Trials of Interventions to Prevent Sexually Transmitted Infections: Learning From the Past to Plan for the Future
Open Access
- 1 April 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Epidemiologic Reviews
- Vol. 32 (1), 121-136
- https://doi.org/10.1093/epirev/mxq010
Abstract
Globally, sexually transmitted infections (STIs) represent a significant source of morbidity and disproportionately impact the health of women and children. The number of randomized controlled trials testing interventions to prevent STIs has dramatically increased over time. To assess their impact, the authors conducted a systematic review of interventions to prevent sexual transmission or acquisition of STIs other than human immunodeficiency virus, published in the English-language, peer-reviewed literature through December 2009. Ninety-three papers reporting data from 74 randomized controlled trials evaluating 75 STI prevention interventions were identified. Eight intervention modalities were used: behavioral interventions (36% of interventions), vaginal microbicides (16%), vaccines (16%), treatment (11%), partner services (9%), physical barriers (5%), male circumcision (5%), and multicomponent (1%). Overall, 59% of interventions demonstrated efficacy in preventing infection with at least 1 STI. Treatment interventions and vaccines for viral STIs showed the most consistently positive effects. Male circumcision protected against viral STIs and possibly trichomoniasis. Almost two-thirds of behavioral interventions were effective, but the magnitude of effects ranged broadly. Partner services yielded similarly mixed results. In contrast, vaginal microbicides and physical barrier methods demonstrated few positive effects. Future STI prevention efforts should focus on enhancing adherence within interventions, integrating new technologies, ensuring sustainable behavior change, and conducting implementation research.Keywords
This publication has 110 references indexed in Scilit:
- Adult Male Circumcision Does Not Reduce the Risk of IncidentNeisseria gonorrhoeae, Chlamydia trachomatis,orTrichomonas vaginalisInfection: Results from a Randomized, Controlled Trial in KenyaThe Journal of Infectious Diseases, 2009
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- Male Circumcision for the Prevention of HSV-2 and HPV Infections and SyphilisNew England Journal of Medicine, 2009
- Effect of Male Circumcision on the Prevalence of High-Risk Human Papillomavirus in Young Men: Results of a Randomized Controlled Trial Conducted in Orange Farm, South AfricaThe Journal of Infectious Diseases, 2009
- The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, UgandaAmerican Journal of Obstetrics and Gynecology, 2008
- Eban HIV/STD Risk Reduction Intervention: Conceptual Basis and ProceduresJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Tailored intervention to increase dual-contraceptive method use: a randomized trial to reduce unintended pregnancies and sexually transmitted infectionsAmerican Journal of Obstetrics and Gynecology, 2008
- Randomised controlled trial of alternative male and female condom promotion strategies targeting sex workers in MadagascarSexually Transmitted Infections, 2007
- A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseasesAmerican Journal of Obstetrics and Gynecology, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006